AIG
GYRE icon

American International Group’s Gyre Therapeutics GYRE Stock Holding History

American International Group’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,392
Closed -$90 – 3192
2021
Q1 		$90 Buy
2,392
+683
+40% +$31.2K ﹤0.01% 2768
2020
Q4 		$81 Sell
1,709
-50
-3% -$2.17K ﹤0.01% 2758
2020
Q3 		$57K Buy
1,759
+338
+24% +$13.2K ﹤0.01% 2834
2020
Q2 		$63K Buy
+1,421
New +$66.7K ﹤0.01% 2791
2019
Q2 		– Sell
-1,010
Closed -$61K – 3128
2019
Q1 		$61K Sell
1,010
-33
-3% -$2.12K ﹤0.01% 2814
2018
Q4 		$62K Sell
1,043
-8
-0.8% -$590 ﹤0.01% 2808
2018
Q3 		$85K Buy
1,051
+19
+2% +$1.5K ﹤0.01% 2914
2018
Q2 		$90K Buy
+1,032
New +$181K ﹤0.01% 2837
2015
Q2 		– Sell
-1
Closed -$1.49K – 5162
2015
Q1 		$1.49K Hold
1
– – ﹤0.01% 4883
2014
Q4 		$1.77K Hold
1
– – ﹤0.01% 4827
2014
Q3 		$1.26K Hold
1
– – ﹤0.01% 4866
2014
Q2 		$2.25K Sell
1
-24
-96% -$78.3K ﹤0.01% 4751
2014
Q1 		$92.5K Buy
25
+1
+4% +$3.7K ﹤0.01% 3492
2013
Q4 		$79K Hold
24
– – ﹤0.01% 3523
2013
Q3 		$102K Hold
24
– – ﹤0.01% 3311
2013
Q2 		$82.2K Buy
+24
New +$91.3K ﹤0.01% 3285

Other funds holding GYRE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

American International Group's GYRE Position: Q2 2021 in Review

American International Group sold out of Gyre Therapeutics (GYRE) in Q2 2021, closing a stake of 2,392 shares — an estimated $90 sold.

American International Group first reported a position in GYRE in Q2 2013 and held it in 16 quarters. The position peaked at $102K in Q3 2013. 69 funds tracked by Wall St. Rank hold GYRE as of Q2 2021.

  • American International Group reported no remaining Gyre Therapeutics position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 2,392 Gyre Therapeutics shares in Q2 2021, an estimated $90.
  • American International Group first reported a position in Gyre Therapeutics in Q2 2013 and held it in 16 quarters.
  • American International Group's Gyre Therapeutics position peaked at $102K in Q3 2013.
  • 69 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.